Cite
MLA Citation
Nicholas Rebold et al.. “Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.” Open forum infectious diseases, vol. 8, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100148045470.0x000009